Business strategy when moving to more regulatory complex markets

Webinar Market understanding, market analytics, current and future competition.

The development of a new marine product for new markets can be challenging and it needs an upstream business plan to maximize your chances of success in a market with higher costs, long development times and higher risks. Regulatory requirements, analyse documentations and also competition are often higher when you move into a high value market.

What are the bottlenecks or limitations? What will new types of investors expect to see in my business case and what are the expected return on investment ?
Find out how to navigate between new commercial opportunities, market considerations and a complex regulatory landscape.

Areas can include, but are not limited to: Materials from new species, nutraceuticals moving to pharmaceuticals, developing rest materials to new valuable products, and more.

Who can participate?

Participating companies will ideally have interests in one or more of these fields: marine biological materials, nutraceutical industry, pharmaceutical industry

Participants should be inspired to identify, describe, and share knowledge about future opportunities to build new health industry products from the ocean.

Registration and detailes : https://www.eventbrite.com/e/strategy-workshop-marine-for-health-tickets-126278521457

Program:

10. December 10.00-12.30

Programme: Market understanding, market analytics, current and future competition - 

1. Emilie Lasson, SVP, North Sea Therapeutics and Hilde Steineger, COO, North Sea Therapuetics: Market analysis – do we build on the right assumptions? Get insight into available tools and databases, target product profile, current and future competitor analysis business plan, Return on Investment (ROI) calculations and product portfolio strategy.

2. Hogne Hallaråker, CSO and Ole Arne Eiksund, CEO, Arctic Nutrition:

Herring as a natural raw material for dietary supplements and pharmaceutical products – considerations and analysis of new opportunities

Our contributors:

Emilie Lasson, PhD, Senior Vice President, North Sea Therapeutics: Currently Senior Vice President of Project Management in NorthSea Therapeutics B.V a spin of from BASF. EU based Biotech company with the goal to develop therapies for NASH and other metabolic, inflammatory and fibrotic diseases. Previously worked in Diagnostics and Biotech in companies such as Genetic Analysis AS, BASF, Dynal/Thermo Fischer, Alpharma/Xellia pharmacuticals. Expertise in Project Management, Innovation and Business Development as well as Sales and Marketing. Experience with analysing new markets and developing business plans both within the pharmaceutical and nutraceutical sector. LINKEDIN

Hilde Steineger, COO, North Sea Therapeutics : Previously Head of Strategic Innovation Management, Nutrition and Health, BASF/Pronova.LINKEDIN

Hogne Hallaråker, Arctic Nutrition: Founder and developer of Arctic Nutrition's business concept. He is an entrepreneur with more than 15 years of experience in the nutraceutical and biomarine industries. He holds a MSc in Marine Biology and Aquaculture from the University of Bergen.LINKEDIN

Ole Arne Eiksund, CEO, Arctic Nutrition: More than 25 years of experience from the pharmaceutical industry, including the position as Commercial Director in GlaxoSmithKline. Former positions include Executive Vice President in Rimfrost AS and VP Global Sales in Hofseth Biocare AS. LINKEDIN